Whole-genome sequencing of pathogenic organisms directly from clinical samples combines 11 detection and genotyping in one step. This can speed up diagnosis, especially for slow-growing 12 organisms like Mycobacterium tuberculosis (Mtb), which need considerable time to grow in 13 subculture, and can provide vital information for effective personalised treatment. Within the 14 PATHSEEK project, we have developed a bait-capture approach to selectively enrich DNA/RNA from 15 specific bacterial and viral pathogens present in clinical samples. Here, we present a variation of the 16 method that allows enrichment of large fragments of target DNA for sequencing on an Oxford 17 Nanopore MinION™ sequencer. We enriched and sequenced cDNA from Influenza A (FluA), genomic 18 DNA (gDNA) from human cytomegalovirus (CMV) and from two strains of Mtb, and present an 19 evaluation of the method together with analysis of the sequencing results from a MinION™ and an 20 Illumina MiSeq sequencer. While unenriched FluA and CMV samples had no reads matching the 21 target organism due to the high background of DNA from host cell lines, enriched samples had 56.7% 22 and 90.9% on-target reads respectively for the best quality Nanopore reads. 23 genomic fragments were readily purified from a background of the cell line used for producing the 49 viruses, or, in case of Mtb, admixed human DNA. 50 51 52 53
Introduction 24
Amidst increased occurrence of extensive or totally drug-resistant pathogens and antibiotic 25 overuse 1 , high-throughput sequencing methods, particularly those which can be readily applied in a 26 clinical setting, are being used to aid and refine diagnosis in a timely fashion 2 . Data from whole-27 genome sequencing provides a wealth of information such as identification of resistance markers 28 carried by the infecting agent(s), allowing for rapid, targeted and personalised treatment. However, 29 DNA extracted from clinical samples consists of a mixture of low amounts of pathogen genetic 30 material and overwhelming quantities of human and commensal DNA. Previous studies have shown 31 that it is possible to bypass the traditional culture-based diagnosis and obtain informative sequence 32 data from metagenomic samples, but the throughput is low and the method prohibitively costly 3 . 33
The EU-funded FP7 PATHSEEK project (http://www.pathseek.eu/) has developed a disruptive 34 diagnostic platform to sequence bacterial and viral pathogens directly from clinical samples 4, 5 . This 35 enrichment approach employs custom baits to capture genomic material from the target pathogens, 36 thereby removing the human and commensal DNA, and allowing greater throughput of samples on 37
Illumina sequencers. However, as this method is optimised for short-read sequencers such as the 38 Illumina MiSeq and the Ion PGM, it is very difficult to resolve highly repetitive regions such as those 39 found in cytomegalovirus 6 , or provide evidence of recombination events such as those seen in 40
Chlamydia trachomatis. Members of the PATHSEEK consortium joined the Oxford Nanopore 41 Technologies (ONT, Oxford, UK) MinION™ access program to assess the suitability of its long-read 42 platform, the MinION™, for the targeted enrichment method. 43
Here, we present an adaption to the PATHSEEK method -enrichment of DNA fragments of between 44 1 and 15 kb for sequencing on long-range platforms. We compare sequence data from unenriched 45 and enriched cultured FluA and CMV samples, run on the MinION™ and Illumina (San Diego, CA, 46 USA) MiSeq platforms. We also mixed cultured Mtb gDNA from two different strains with human 47 DNA to assess the efficiency of enrichment by hybridisation for longer bacterial DNA fragments. Long 48 were hybridised and captured using 2 μl FluA and CMV baits, or 5 μl for Mtb baits per reaction. 88 Hybridisation and washing were performed using a modified version of the SureSelect XT Target 89 Enrichment for Illumina Paired-End Multiplexed Sequencing as described previously 4, 5 . The workflow 90 used in this study is outlined in Figure 1 .Samples (30 μl) were then heated to 95°C for 3 min, and 91 cooled to 35°C (ramp: 4°C/min) to release the target fragments from the baits and streptavidin 92 beads. 93
Hybridised samples were split into two aliquots and half was used for Nanopore library preparation 94 with ONT kit versions SQK-MAP003 for Mtb H37Rv and SQK-MAP004 for CMV, FluA, MtbC. The 95 remainder was used to generate Illumina-compatible libraries, using another modified version of the 96 SureSelect XT Target Enrichment for Illumina Paired-End Multiplexed Sequencing (Figure 1 ). 97 98 Nanopore library preparation, sequencing and analysis 99
Following renaturation, end repair and dA-tailing were performed with enzymes from the 100 SureSelect XT kit (#5500-0075, Agilent) as specified by the manufacturer. AMPure XP-purified, dA- A second round of end repair and dA-tailing was performed on 1 μg of enriched, amplified PCR 110 product using SureSelect XT reagents as described above, but without purification after dA-tailing. 111
Instead, leader/hairpin ligation and sample clean-up were performed according to the ONT protocol 112 for kit SQK-MAP003 (for strain Mtb H37Rv only) or SQK-MAP004, in protein LoBind tubes (1.5 ml, 113 #0030108116, Eppendorf). In detail, 10 μl adapter mix and 2 μl hairpin adapter (ONT) were 114 incubated for 10 min at room temperature with 30 μl dA-tailed sample and 50 μl 2x blunt/TA ligase 115 master mix (#M0367, NEB) in 100 μl volume. SQK-MAP003 libraries were cleaned up with AMPure 116 XP beads, SQK-MAP004 with Dynabeads for His-Tag isolation and pulldown (#10103D, Life 117 Technologies) according to the respective ONT protocols. Libraries were eluted from the beads at 118 room temperature for 10 min with 25 μl elution buffer (ONT). Library concentrations were typically 119 2-10 ng/μl, as assessed by Qubit fluorometer. 120
Before each MinION™ run, flowcells were quality-tested with the script MAP_Platform_QC 121 (MinKnow software version 0.46.2.8 to 0.49.2.9), then loaded with 6 μl library and 4 μl fuel mix in 122 140 μl EP buffer (ONT), and run with script MAP_48Hr_Sequencing_Run, typically for 24h. Reads 123 were analysed by the Metrichor 2D basecalling (versions 2.19 to 2.29) cloud-based platform, and the 124 resulting fast5 files ("pass" and "fail" quality) converted to fasta format with Poretools 8 . BLASR 9 and 125 LAST 10 were used to align reads to the pathogen reference sequences (human CMV herpes virus 126 HHV-5 GU179001.1, Mtb strain H37Rv NC_018143.2, and Influenza strain H1N1, A/Puerto 127 Rico/8/1934 ). Files were further tested with both aligners against background human 128 (Human_g1k_v37, www.1000genomes.org) or dog (Ensembl CanFam3.1 GCA_000002285.2; 129 NC_006583.3) sequences, and the ONT adapters used for PCR. 130
The FluA control sample that did not undergo hybridisation (75 ng) was PCR-amplified to 500 ng as 131 described previously, then prepared as recommended in the ONT Genomic DNA sequencing protocol 132 SQK-MAP004. For the non-hybridised CMV sample, 500 ng was used directly for Nanopore library 133 preparation (SQK-MAP004). 
Results

150
Comparison of Nanopore library size and read length 151 CMV and Mtb gDNA was sheared to fragments of 10-15 kb using Covaris g-TUBEs. FluA cDNA was 152 used without previous shearing for both enriched and non-enriched Nanopore libraries. Table 1  153 shows the median fragment length of the input DNA after shearing, as determined on an Agilent 154 Tape Station. Interestingly, the distribution of the unsheared FluA cDNA on the Tape Station showed 155 distinct peaks of 120 nt, 300 nt, 500 nt, 800 nt, 1-3 kb, with fragments up to 15 kb; these correspond 156 to transcripts from the eight FluA genomic segments NC_002016 to NC_002023, and cell line DNA. 157
PCR-amplified samples had wide ranges of sizes both within and between individual reactions, with 158
PCR products about half the size of the original DNA used for hybridisation. The Nanopore reads 159 (raw data in the European Nucleotide Archive, Study PRJEB12651) were similarly variable in length, 160 as indicated by the size of the standard deviations in Table 1 . "Pass" quality (both strands read while 161 passing through the nanopore, resulting in higher confidence) reads were, on average, 1.2 to 4.2x 162 the length of "fail" quality reads. PCR-amplified samples were considerably smaller than the original 163 DNA fragments. Sequenced reads were shorter still, but with a wide range, reflected in high 164 standard deviations in 
Comparison of BLASR and LAST aligners 175
We used BLASR 9 and LAST 10 (with the settings used in Quick et al. 11 ) for the alignment of Nanopore 176 reads to their respective references (pathogen and human/dog cell line). We found that BLASR 177 alignment resulted in fewer reads, with higher identity to the reference strains, and lower standard 178 deviation. In contrast, the LAST aligner produced more reads aligning to the reference, with lower 179 identity and higher standard deviation. Table 2 shows statistics for the similarities to the target 180 references obtained with the two aligners. 181 182 Most "pass" quality reads aligned to either the target organism or the respective cell line, whereas 186 most "fail" quality reads did not match to either target, cell line, or sequences in the PubMed 187 Nucleotide database (November 2015) . A small number of FluA (85), CMV (315) and MtbC (10) 188 Nanopore reads matched to both target pathogen and cell line, predominantly in the output of the 189 LAST aligner (Table 3) Amplification and subsequent sequencing of the long DNA fragments demonstrates the success of 198 the hybridisation and library preparation for both Nanopore and Illumina sequencing. Analysis of the 199 42261 reads obtained from a non-enriched, PCR-amplified FluA cDNA library run on the Nanopore 200 MinION TM found 75.2% pass and 23.7% fail reads aligned to the MDCK dog cell line used for 201 cultivation of the virus, whilst only one read aligned to the FluA reference H1N1. After hybridisation 202 and amplification, 57.2% of pass and 9.5% of fail reads (34211 reads in total) from a Nanopore run 203 could be aligned to FluA. This amounts to a total FluA coverage of 71.2x. Though there was generally 204 good coverage across the eight FluA segments, Figure 2 shows a wide variation of number of reads 205 per fragment, as well as distinct peaks of coverage of FluA cDNA. Similarly, the frequency of cell line 206 reads dropped to 49.4% (pass) and 8.2% (fail) ( Table 3) . 207
208
The un-enriched CMV library (432 unique reads in total) produced five reads (1.2%) matching the 209 CMV reference HHV-5, while 97 reads (22.5%) matched the human_g1k_v37 reference. After 210 hybridisation of the DNA with the CMV-specific bait set, we obtained 37589 reads from three runs, 211 with almost all (98.7%) pass reads and 35% of fail reads aligning to the CMV reference. This amounts 212 to a coverage of 89.9x of the CMV genome. Figure 3 shows the output of these reads aligned to the 213 reference. 214 215 A comparison of the consensus sequence generated from the enriched CMV reads aligned to the 216 CMV HHV-5 reference using the genomic similarity search tool YASS 14 found the former had 99.4% 217 similarity to the reference (233854 of 235230 nucleotide residues). The conflicting/mismatch 218 residues are mostly gaps in the Nanopore consensus sequence at 46364-46433 (proteins UL34 and 219 UL35), 147820-147830 (helicase-primase subunit UL102), 194363-194698 and 195851-95977 . The 220 last two regions of difference coincide with inverted repeat regions 6 (194344 to 195667, 195090 to 221 197626) . A number of mismatches to the reference HHV-5 were identified upstream of base 1270; 222 these were due to low coverage of this region by Nanopore reads. We found regions with low (<5x) 223 coverage had a high number of mismatches compared to the reference, but areas of greater 224 coverage matched near-perfectly. 225
226
For Mtb strain H37Rv, we obtained 2028 unique pass and 9961 unique fail reads (0.077x coverage), 227 for the strain MtbC, 202 pass and 46711 fail reads (0.182x). Distribution of reads from both Mtb 228 strains aligning to the H37Rv genome is relatively even (Figure 4) . Localized high-coverage areas with 229 multiple reads in both strains were found at a number of genomic positions encoding transposases, 230 e.g. 887488-887429, 890363-889044, 1539822-1538580, 2640242-2635594, 3547252-3544391, 231 3789669-3788312 of strain H37RV (NC_018143.2). The areas with increased coverage can also be 232 observed in Illumina-generated datasets (Figure 4) , presumably due to the redundancy of the 233 sequence, which could result in localised increased aligning of reads. 234
235
Sequencing of enriched long fragments on the Illumina MiSeq 236
To assess the success of the long fragment hybridisation, Illumina libraries were generated from half 237 of the hybridised material, and sequenced on a MiSeq (Table 4 ). The coverage profile from the 238 enriched FluA and Mtb samples produced similar distribution, and reads from both the Nanopore 239 and Illumina sequencers showed preferential enrichment of the same regions (Figure 4 shows Mtb). 240
In contrast, aligned Nanopore CMV reads generated from the long fragment-enriched sample had a 241 slightly different coverage profile to their Illumina counterpart. The longer Nanopore reads formed 242 wide peaks, whilst mapped Illumina reads clustered in narrow stacks with deep troughs (Figure 5) . 243
This could be due to the positioning of baits, which could preferentially enrich short fragments that 244 overlap well with them. Some gaps are visible in the Nanopore coverage, these are bridged by 245 relatively few reads and do not always correspond to gaps in the Illumina coverage. 246 247 This study explores the enrichment of long fragments using baits designed and used in previous 254 studies 4, 5 for whole-genome sequencing of specific pathogens from clinical or mixed samples. These, 255 instead of the 200 nt strands conventionally used for Illumina library construction, give a wider 256 range of possibilities for the deconvolution of repeat regions, detection of translocations and larger 257 indels, or mate-pair libraries. Pathogens with small genomes, in our case cDNA from FluA, could be 258 sequenced without previous shearing, potentially preserving structural information and avoiding 259 assembly problems. We show that the enriched long fragments can be used for libraries for both 260
Illumina sequencers (after re-shearing), and the third-generation long-range sequencer Oxford 261 Nanopore MinION™. The portable, relatively inexpensive, and low-footprint MinION™ sequencers 262 have been used in settings where conventional Illumina sequencing would be difficult 15 . Nanopore 263 sequencing has previously been used to detect structural variants in large genomes 16 ; our method 264 could be employed as a non-amplicon-based alternative for this application. As the enrichment 265 approach is platform-agnostic, it could also be used to generate libraries compatible with the PacBio 266 RS II and Sequel systems. 267 Previous work 17 has shown that detection of moderate to high titres of pathogen DNA (chikungunya 268 virus, Ebola and Hepatitis C virus) from human blood samples is possible using Nanopore 269 sequencing. However, this direct sequencing approach cannot take full advantage of the capabilities 270 of sequencing for strain typing and variant identification, especially in bacterial infections, due to 271 their larger genomes, and/or low titre samples. In our Nanopore sequencing runs with un-enriched 272
FluA or CMV DNA, we detected very low numbers of reads from the pathogen compared to those 273 from the host cell line culture. In contrast, sequencing data from enriched DNA produced good 274 coverage of the FluA and CMV genomes and partial coverage of the Mtb genome. High and even 275 coverage of the target pathogen genome 18 , gained through targeted enrichment, can compensate 276 for the errors seen in Nanopore sequencing, and facilitate the detection of potential resistance to 277 antibiotics and identification of mixed infections and minor variants. 278
We found Illumina sequencing results from material derived from long fragment hybridisation (Table  279 4) showing good and even coverage, similar to the standard PATHSEEK method of short-fragment 280 hybridisation 4, 5 . This, together with the fact that high-molecular weight post-enrichment fragments 281 could be readily ligated and amplified, highlights the suitability for long fragments for hybridisation 282 and its downstream applications. 283
We analysed our Nanopore datasets with two different aligners -BLASR produced fewer reads with 284 higher identity to the target pathogen and lower standard deviation, LAST identified more reads 285 with lower identity and higher standard deviation, similar to the results of Kilianski et al. 19 . The 286 difference of up to 40% in sequences identified as matches to the reference between the two 287 aligners, highlights that neither works optimally for aligning Nanopore reads to their reference. A 288 small number of reads reported as containing both cell line and pathogen matches, mainly from the 289 output of LAST, could not be confirmed. As reported elsewhere 17, 19 , a large percentage of Nanopore 290 reads (mainly the "fail" quality) could not be aligned to either the target pathogen, or human (Mtb), 291 the human cell line (CMV) or the dog cell line (FluA), respectively, and show no similarities when 292 compared to the NCBI Nucleotide Database (November 2015) . 293
294
The persisting, and, in some cases, increasing pressure of pathogenic viruses and bacteria on human 295 and animal health underlines the need for fast, accurate and up-to-date diagnosis. Next-generation 296 sequencing can enable clinicians to identify both pathogen species and genotype in one step, 297 significantly aiding individual treatment with respect to drug resistance 20 and monitoring of 298 outbreaks 21 . The increasing interest in whole-genome sequencing for diagnosis has led to the drive 299 to take it out of the research environment and into the clinic to reduce the time between taking a 300 specimen, identifying the pathogen and obtaining actionable genomic data. Nanopore sequencing, 301 coupled with data streaming and real-time analysis, has the possibility to bring sequencing closer to 302 patient, or to be used in settings without easy access to an Illumina machine. The Nanopore 303 sequencing platform, coupled with our long-fragment enrichment method, can be applied to a range 304 of pathogens and clinical samples. However, our experiments were performed with a 16-hour 305 hybridisation reaction, a time-consuming and rate-limiting step. In the future, this has the potential 306 to be shortened to four hours by using a different hybridisation protocol. Though not tested in this 307 study, addition of molecular bar-codes as outlined in the "Sequencing using the PCR Barcoding Kit" 308 ONT protocol, will allow for several clinical samples of enriched viral DNA to be run simultaneously 309 on one MinION™ flowcell. This, coupled with increasing accuracy of the MinION™ reads, will also 310 reduce the coverage necessary for strain and variant identification, making this method suitable for 311 diagnostic purposes in the future. herpes virus HHV-5 GU179001.1, positions 60,000-80,000, visualised in IGV. The longer Nanopore 414 reads cover the reference more evenly but show some gaps that are well-covered by Illumina reads. 415 416 417
